Francisco Coret - Concepedia

Author

Francisco Coret

Hospital Universitari i Politècnic La Fe

Also Known As

E. Agüera, F Coret, F. Coret, Francisco Coret, Francisco Coret Ferrer, Y. Aladro

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitari i Politècnic La Fe Hospital Clínico Universitario de Valencia Hospital Universitario Ramón y Cajal Hospital Universitario Doctor Peset Hospital Universitari de Vic

About

Francisco Coret is an author at Hospital Universitari i Politècnic La Fe specializing in medicine, multiple sclerosis, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	535
2	Social Sciences	4	4	114
3	Immunology	4	4	138
4	Health Sciences	3	3	83
5	Gastroenterology	1	1	33

Francisco Coret

Publications

908

Citations

H-Index

Page 1

	Year	Citations
Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation Eduardo Beltrán, Birgit Obermeier, Markus Moser, Brain	2014	77
Immunoglobulin <scp>M</scp> oligoclonal bands: Biomarker of targetable inflammation in primary progressive multiple sclerosis Luisa María Villar, Bonaventura Casanova, Nadia Ouamara, Annals of Neurology	2014	64
Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes María José Magraner, Isabel Boscá, María Simó, Neuroradiology Brain AtrophyNeurological DisorderMedicineLesion LoadBrain Injury	2011	62
Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis Bonaventura Casanova, Isidro Jarque, Francisco Gascón, Neurological Sciences	2017	58
Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required Ana María Jiménez Pascual, N. Téllez, Isabel Boscá, Multiple Sclerosis Journal Incidence DensityHematological MalignancyMultiple Sclerosis PopulationsOncologyMixed-phenotype Acute Leukemia	2009	57
Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study Carmen Alcalá, Francisco Gascón, Francisco Pérez‐Miralles, Journal of Neurology Hospital-based StudyImmunologyClinical TrialsProgressive Multiple SclerosisMultiple Sclerosis	2018	57
Lipid‐specific immunoglobulin <scp>M</scp> bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab Luisa María Villar, Lucienne Costa‐Frossard, Thomas Masterman, Annals of Neurology	2015	51
Evidence of Wallerian degeneration in normal appearing white matter in the early stages of relapsing-remitting multiple sclerosis Bonaventura Casanova, M. C. Mart�nez-Bisbal, C. Valero, Journal of Neurology Neurodegenerative DiseasesNeurobiology Of DiseaseRelapsing-remitting Multiple SclerosisNeurological DisorderMedicine	2003	49
Pulsed steroids followed by glatiramer acetate to prevent inflammatory activity after cessation of natalizumab therapy: a prospective, 6-month observational study María José Magraner, Francisco Coret, Arantxa Navarré, Journal of Neurology InflammationNatalizumab TherapyInflammatory ActivityAnti-inflammatoryAutoimmune Disease	2011	44
CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis Luisa María Villar, Thomas Masterman, Bonaventura Casanova, Journal of Neuroimmunology Neurobiology Of DiseaseAutoimmune DiseaseNeurological DisorderMedicineNeuroepidemiology	2009	40

Page 1